Lenox Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-95
Closed -$3K 708
2019
Q3
$3K Buy
+95
New +$4.03K ﹤0.01% 588
2017
Q3
Sell
-692
Closed -$19K 479
2017
Q2
$19K Buy
+692
New +$18.4K 0.01% 310

Other funds holding BSX

Lenox Wealth Management's BSX Position: Q4 2019 in Review

Lenox Wealth Management sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 95 shares — an estimated $3K sold.

Lenox Wealth Management first reported a position in BSX in Q2 2017 and held it in 2 quarters. The position peaked at $19K in Q2 2017. 853 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

  • Lenox Wealth Management reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
  • Lenox Wealth Management sold 95 Boston Scientific shares in Q4 2019, an estimated $3K.
  • Lenox Wealth Management first reported a position in Boston Scientific in Q2 2017 and held it in 2 quarters.
  • Lenox Wealth Management's Boston Scientific position peaked at $19K in Q2 2017.
  • 853 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Lenox Wealth Management's 13F filing for Q4 2019, filed 29 Jan 2020.